129 related articles for article (PubMed ID: 20638228)
1. Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease.
Ishii H; Kumada Y; Toriyama T; Aoyama T; Takahashi H; Murohara T
J Vasc Surg; 2010 Oct; 52(4):854-9. PubMed ID: 20638228
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factor.
Bleda S; de Haro J; Varela C; Acin F
J Endovasc Ther; 2015 Apr; 22(2):233-9. PubMed ID: 25809368
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease.
Ishii H; Aoyama T; Takahashi H; Kamoi D; Tanaka M; Yoshikawa D; Hayashi M; Matsubara T; Murohara T
Atherosclerosis; 2013 Mar; 227(1):130-4. PubMed ID: 23294924
[TBL] [Abstract][Full Text] [Related]
5. Impact of Calcification on Clinical Outcomes After Endovascular Therapy for Superficial Femoral Artery Disease: Assessment Using the Peripheral Artery Calcification Scoring System.
Okuno S; Iida O; Shiraki T; Fujita M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Takahara M; Uematsu M
J Endovasc Ther; 2016 Oct; 23(5):731-7. PubMed ID: 27369975
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
[TBL] [Abstract][Full Text] [Related]
7. Endovascular treatment of hemodialysis-induced lower limb artery ischemia: retrospective analysis from a single center.
Wang P; Yang F; Yin J; Zhu H; Zhang M; Liu C
Ann Palliat Med; 2021 Apr; 10(4):4661-4669. PubMed ID: 33966414
[TBL] [Abstract][Full Text] [Related]
8. Three-year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in hemodialysis patients with minor or major tissue loss.
Nakano M; Hirano K; Yamauchi Y; Iida O; Soga Y; Kawasaki D; Yamaoka T; Suematsu N; Suzuki K
Catheter Cardiovasc Interv; 2015 Aug; 86(2):289-98. PubMed ID: 25256632
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Isolated Tibial Endovascular Interventions for Tissue Loss in CLI Patients on Hemodialysis.
Davies MG; El-Sayed HF
J Endovasc Ther; 2015 Oct; 22(5):681-9. PubMed ID: 26286072
[TBL] [Abstract][Full Text] [Related]
11. Propensity score analysis of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia.
Soga Y; Mii S; Iida O; Okazaki J; Kuma S; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Kamoi D; Shintani Y
J Endovasc Ther; 2014 Apr; 21(2):243-53. PubMed ID: 24754284
[TBL] [Abstract][Full Text] [Related]
12. Preprocedural hemoglobin predicts outcome in peripheral vascular disease patients undergoing percutaneous transluminal angioplasty.
Toor IS; Jaumdally RJ; Moss MS; Babu SB
J Vasc Surg; 2009 Aug; 50(2):317-21. PubMed ID: 19631867
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of infrapopliteal endovascular procedures for hemodialysis patients with critical limb ischemia.
Nakano M; Hirano K; Iida O; Yamauchi Y; Soga Y; Kawasaki D; Tazaki J; Suzuki K; Fujiwara M; Yamaoka T
Ann Vasc Surg; 2015 Aug; 29(6):1225-34. PubMed ID: 26004963
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
[TBL] [Abstract][Full Text] [Related]
15. Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation.
Nakazawa KR; Wengerter SP; Power JR; Lookstein RA; Tadros RO; Ting W; Faries PL; Vouyouka AG
J Vasc Surg; 2017 Jul; 66(1):151-159. PubMed ID: 28259571
[TBL] [Abstract][Full Text] [Related]
16. Stent placement in the superficial femoral artery for patients on chronic hemodialysis with peripheral artery disease.
Nishibe T; Kondo Y; Dardik A; Muto A; Koizumi J; Nishibe M
Int Angiol; 2009 Dec; 28(6):484-9. PubMed ID: 20087287
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions.
Iida O; Soga Y; Yamauchi Y; Hirano K; Kawasaki D; Yamaoka T; Takahara M; Uematsu M
J Vasc Surg; 2013 Apr; 57(4):974-981.e1. PubMed ID: 23375608
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions.
Iida O; Soga Y; Hirano K; Kawasaki D; Suzuki K; Miyashita Y; Terashi H; Uematsu M
J Vasc Surg; 2012 Feb; 55(2):363-370.e5. PubMed ID: 22051875
[TBL] [Abstract][Full Text] [Related]
19. Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).
Takamura TA; Tsuchiya T; Oda M; Watanabe M; Saito R; Sato-Ishida R; Akao H; Kawai Y; Kitayama M; Kajinami K
Atherosclerosis; 2017 Aug; 263():192-197. PubMed ID: 28651186
[TBL] [Abstract][Full Text] [Related]
20. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
